Bringing a new medicine to market can take 10 to 15 years and cost up to $2.6 billion per drug. Yet, 70% of clinical trial drugs are wasted due to supply chain inefficiencies. Why? Because clinical trials face unique challenges—from unpredictable patient enrollments and complex study designs to strict regulatory demands. Unlike commercial supply chains, they need a tailored planning solution.
Introducing the next-generation clinical supply chain planning tool on the Kinaxis Maestro platform. This solution delivers Real-Time Visibility into trial drug supplies, enabling real-time inventory monitoring. Its Scenario Planning simulates supply chain disruptions while balancing demand and supply for optimal inventory. With Regulatory Compliance, it meets FDA, EMA, and global standards, while Inventory Optimization, Shelf-life planning and Regulatory Compliance Planning it minimizes waste and prevents shortages. By generating Calculated demand curves based on study design, it simplifies forecasting, supported by Agile Product Life Cycle Management and E2E Visibility connecting your Commercial to your R&D Supply network.
The benefits are clear—hundreds of hours saved every S&OP cycle, a 30% reduction in lead times, a 53% shrinkage in the clinical supply product portfolio, and a 20% drop in inventory levels within the first year, all while improving waste management.
With over 70% of consultants bringing 15-plus years of industry expertise, Genpact partners with Kinaxis as the only full-service value assurance provider with 18 life science implementations. Together, we’re transforming clinical supply chains for leading pharma companies worldwide. Let’s build a smarter, more clinical supply chain together.
montage & motion design Oskar Luijer
scenario & productie André Brocatus